Wolverine Asset Management’s Accelerate Diagnostics AXDX Stock Holding History

Wolverine Asset Management’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-469	Closed	-$4.14K	–	2332
2022 Q1	$6K	Buy	469 +186	+66%	+$5.3K	﹤0.01%	1987
2021 Q4	$14K	Hold	283	–	–	﹤0.01%	1795
2021 Q3	$16K	Hold	283	–	–	﹤0.01%	1682
2021 Q2	$22K	Buy	+283	New	+$22.5K	﹤0.01%	1881
2018 Q2	–	Sell	-118	Closed	-$26.4K	–	1390
2018 Q1	$26K	Buy	+118	New	+$31K	﹤0.01%	1330

Other funds holding AXDX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BAM

Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

TWA

TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wolverine Asset Management's AXDX Position: Q2 2022 in Review

Wolverine Asset Management sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 469 shares — an estimated $4.14K sold.

Wolverine Asset Management first reported a position in AXDX in Q1 2018 and held it in 5 quarters. The position peaked at $26K in Q1 2018. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.

Wolverine Asset Management reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
Wolverine Asset Management sold 469 Accelerate Diagnostics shares in Q2 2022, an estimated $4.14K.
Wolverine Asset Management first reported a position in Accelerate Diagnostics in Q1 2018 and held it in 5 quarters.
Wolverine Asset Management's Accelerate Diagnostics position peaked at $26K in Q1 2018.
74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.

Based on Wolverine Asset Management's 13F filing for Q2 2022, filed 3 Aug 2022.